Login

HTC CEO Yves Maitre discusses the impact of trade tensions, the competitive landscape of the 5G race, and strategic company responses. 00:10:00

Share On Facebook Share On Twitter

Cher Wang serves as the CEO / President of HTC Corp.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Unlocking Real Assets for Retail Investors: Insights from Dale Holmes of Spire Capital | Dale Holmes - Investment Strategist, Spire Capital"
00:10:00
Transitioning from IV infusions to subcutaneous injections can indeed make a significant difference in patient comfort and convenience|Lynn Hartung,President,Qprotyn
00:10:00
Sarama Resources: Regaining Control and Advancing Gold Exploration in West Africa
00:10:00
How has the market impacted investment & CISO buying strategies|Yoav Andrew Leitersdorf,Managing Partner,YL Ventures
00:10:00
CEO of Helm Audio discusses funding success on Kickfurther.
00:10:00
The Prospect Generator Model with one of the foremost and respected names in the Sector Mr. Morgan Poliquin|Morgan Poliquin,CEO, Almaden Minerals
00:10:00
ASBISc Enterprises Plc, Costas Tziamalis – Deputy CEO of ASBIS Group | COSTAS TZIAMALIS, CEO, ASBISc Enterprises PLCASB:WSE
00:10:00
Where the world is headed versus where it currently exists|Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
VEON CEO Kaan Terzioğlu discusses third-quarter earnings, raising full-year guidance, and reducing investment.
00:00:00
Joseph T. Breen, M.D. Otolaryngologist, Mayo Clinic
00:10:00
Skillz CEO Andrew Paradise addresses concerns raised in a short-seller note.
00:10:00
founded companies that went public and invested in unicorns|Aaron Stachel,Partner,FirstMile Ventures

© 2017 - Neuhu+